Canada markets close in 1 hour 47 minutes

ICL Group Ltd (ICL.TA)

Tel Aviv - Tel Aviv Delayed Price. Currency in ILA (0.01 ILS)
Add to watchlist
1,944.00-1.00 (-0.05%)
At close: 05:24PM IST
Full screen
Previous Close1,945.00
Open1,988.00
Bid1,944.00 x 20100
Ask1,945.00 x 1591600
Day's Range1,936.00 - 2,000.00
52 Week Range1,629.00 - 2,485.00
Volume3,543,298
Avg. Volume1,891,110
Market Cap25.069B
Beta (5Y Monthly)0.58
PE Ratio (TTM)10.68
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.70 (3.58%)
Ex-Dividend DateMar 14, 2024
1y Target EstN/A
  • Business Wire

    ICL Files 2023 Annual Report on Form 20-F

    TEL AVIV, Israel, March 14, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint.

  • Business Wire

    ICL Accelerating Biologicals Portfolio Growth in Brazil with Strategic Acquisition

    TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it has acquired Nitro 1000, a manufacturer, developer and provider of biologicals in Brazil for approximately $30 million. This acquisition marks another meaningful step into the biologicals market, while expanding ICL’s product offerings and positioning the company for further expansions into new and adjacent end-markets.

  • Business Wire

    ICL Reports Fourth Quarter and Full Year 2023 Results

    TEL AVIV, Israel, February 28, 2024--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Consolidated annual sales were $7,536 million versus a record $10,015 million in 2022. Net income was $647 million versus $2,159 million, while adjusted net income was $715 million versus $2,350 million. Annual adjusted EBITDA was $1,754 million versus $4,007 million in 2022. Diluted earni